Tags |
|
|
Links |
|
|
Main Subject - Ezines VS. Trade Journals
As many people know Industry Trade Journals in America have gone through a tough time in recent years due to slowing of adver
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
tising dollars. In many industries this is the case. Many of us use to get free Industry Trade Journals, yet many have now
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
one out of business and others are being a little more particular than normal. Some send you questionnaires every three mont
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
s to make sure you are interested and reading their material. Most companies DO NOT advertise in such trade journals. A few
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
o, mostly for brand name recognition, although in my opinion it is a lot of money considering the much lower costs of Ezines
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
nd Internet Advertising. Some believe paper trade journals or Industry Rags as they are often called are waste of advertisin
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
g money, even worse than attending some under attended trade shows.
As advertising dollars continue to dry up and even with
As advertising dollars continue to dry up and even with
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ll the media consolidation, there seems to be a very aggressive approach to sales tactics of these salesmen/women and a touch
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
of unnerving arrogance among the editors, publishers and self-important writers. I guess that arrogance goes with the job, h
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
wever I think it is time for all Industry Journals and media for that matter to come back to Earth, realize their relative va
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ue in our society. Everything has an intrinsic value and an actual value and we need Industry Journals to find equilibrium.
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
Why would any company in any industry waste money on such advertising when they are not getting relevant clients from those
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ds, yet continue to throw good money after bad? Perhaps they themselves want to see their pictures in the ads, perhaps if th
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
y advertise they can get the editors to go ahead and do a story on the company? Maybe we have just too big egos in business?
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What say you? Would you want to buy from a company that blows money on such advertising; money that could be better spent h
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
lping the customer succeed with their product? What does this say to the customer about the price they are paying for those
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
goods are services?
It seems many companies are so busy doing things the old way that they rarely update their websites, nev
It seems many companies are so busy doing things the old way that they rarely update their websites, nev
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
r advertise in Ezines or bother to survey their customers as to how they discovered them in the first place. There is a time
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
and place for Industry paper journals, yet so many companies use those advertising dollars incorrectly rather than diversifyi
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
g those funds to get the most bang for their bucks. I pity such companies and am glad to say we are not one of them? Are you
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/63589/mainsubjects-Ezines-VS-Trade-Journals.html">Ezines VS. Trade Journals</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/63589/mainsubjects-Ezines-VS-Trade-Journals.html]Ezines VS. Trade Journals[/url]
Related Articles:
The Top 10 Ways to Follow-Up with Coaching Clients - Part 2
Want Customer Satisfaction? Sound Curious, Not Angry!
eBay: Discover New System To Unleash The Power
Bookmark it:
|